Age and gender trends in implantable cardioverter defibrillator utilization: A population based study

Journal of Interventional Cardiac Electrophysiology

Volumn 22, Issue 1, 2008, Pages 65-70

  Lin, Grace ^a   Meverden, Ryan A ^a   Hodge, David O ^a   Uslan, Daniel Z ^a   Hayes, David L ^a   Brady, Peter A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Elderly; Gender differences; Implantable cardioverter defibrillator utilization; Outcomes

Indexed keywords

CREATININE;

ADULT; AGE; AGED; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEFIBRILLATOR; FEMALE; GENDER BIAS; HEALTH CARE UTILIZATION; HEART EJECTION FRACTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; TIME SERIES ANALYSIS; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MINNESOTA; SEX FACTORS; STROKE VOLUME;

EID: 44949098551     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-008-9213-6     Document Type: Article

References (15)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337, 1576-1584. Medline. DOI 10.1056/NEJM199711273372202.
2. Moss, A. J., Hall, W. J., Cannom, D. S., et al. (1996). The multicenter automatic defibrillator implantation trial investigators: improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New England Journal of Medicine, 335, 1933-1940. Medline. DOI 10.1056/NEJM199612263352601.
3. Moss, A. J., Zareba, W., Hall, W. J., et al. (2002). The multicenter automatic defibrillator implantation trial II investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877-883. Medline. DOI 10.1056/NEJMoa013474.
4. Bardy, G. H., Lee, K. L., Mark, D. B., et al. (2005). the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225-237. Medline. DOI 10.1056/NEJMoa043399.
5. Blomkalns, A. L., Chen, A. Y., Hochman, J. S., et al. (2005). Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. Journal of the American College of Cardiology, 45, 832-837. Medline. DOI 10.1016/j.jacc.2004.11.055.
6. Chandra, N. C., Ziegelstein, R. C., Rogers, W. J., et al. (1998). Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Archives of Internal Medicine, 158, 981-988. Medline. DOI 10.1001/archinte.158. 9.981.
7. Khan, S. S., Nessim, S., Gray, R., Czer, L. S., Chaux, A., & Matloff, J. (1990). Increased mortality of women in coronary artery bypass surgery: evidence for referral bias. Annals of Internal Medicine, 112, 561-567. Medline.
8. Ruskin, J. N., Camm, A. J., Zipes, D. P., Hallstrom, A. P., & McGrory-Usset, M. E. (2002). Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. Journal of Cardiovascular Electrophysiology, 13, 38-43. Medline. DOI 10.1046/j.1540-8167. 2002.00038.x.
9. Curtis, L. H., Al-Khatib, S. M., Shea, A. M., Hammill, B. G., Hernandez, A. F., & Schulman, K. A. (2007) Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA, 298(13), 1517-1524
10. Hernandez, A. F., Fonarow, G. C., Liang, L., Al-Khatib, S. M., Curtis, L. H., LaBresh, K. A., et al. (2007) Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA, 298, 1525-1532
11. Kurland, L., & Molgard, C. (1981). The patient record in epidemiology. Scientific American, 245, 54-63. Medline.
12. Melton, L. (1996). History of the Rochester epidemiology project. Mayo Clinic Proceedings, 71, 266-274. Medline.
13. Gauri, A. J., Davis, A., Hong, T., Burke, M. C., & Knight, B. P. (2006). Disparities in the use of primary prevention and defibrillator therapy among blacks and women. American Journal of Medicine, 119, 167.e17-167.e21.
14. El-Chami, M. F., Hanna, I. R., Bush, H., & Langberg, J. J. (2007). Impact of race and gender on cardiac device implantations. Heart Rhythm, 4, 1420-1426. Medline. DOI 10.1016/j.hrthm.2007.07.024.
15. Ayanian, J. Z., & Epstein, A. M. (1991). Differences in the use of procedures between women and men hospitalized for coronary heart disease. New England Journal of Medicine, 325, 221-225. Medline.